Eversept Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.6M | Sell |
|
|||||
|
2025
Q1 | $21.7M | Sell |
|
|||||
|
2024
Q4 | $49.4M | Sell |
|
|||||
|
2024
Q3 | $58.3M | Sell |
|
|||||
|
2024
Q2 | $76.7M | Sell |
|
|||||
|
2024
Q1 | $85M | Sell |
|
|||||
|
2023
Q4 | $64.3M | Sell |
|
|||||
|
2023
Q3 | $70.9M | Sell |
|
|||||
|
2023
Q2 | $57.7M | Buy |
|
|||||
|
2023
Q1 | $54.8M | Buy |
|
|||||
|
2022
Q4 | $43M | Buy |
|
|||||
|
2022
Q3 | $32.8M | Sell |
|
|||||
|
2022
Q2 | $33.9M | Buy |
|
|||||
|
2022
Q1 | $38.9M | Buy |
|
|||||
|
2021
Q4 | $18.4M | Sell |
|
|||||
|
2021
Q3 | $34.6M | Sell |
|
|||||
|
2021
Q2 | $37.7M | Sell |
|
|||||
|
2021
Q1 | $50.3M | Buy |
|
|||||
|
2020
Q4 | $26.5M | Buy |
|
|||||
|
2020
Q3 | $21.6M | Buy |
|